Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has been struggling during the past year. Its financial results - ...

But Boeing faces industry supply-chain snags that have delayed some jet production even as planemakers’ backlogs swelled last ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

Eli Lilly ( LLY 1.21%) and Novo Nordisk ( NVO 2.66%) were early leaders in the development of GLP-1 agonists, and dominate the market. Research from MarketsandMarkets suggests that annual global sales ...

Eli Lilly escalates its crackdown on unauthorized tirzepatide copies, filing lawsuits against four compounders accused of ...

CompanyOverview|NYSE:GPC] Genuine Parts Co. (NYSE: GPC) stock is holding on to gains of around 1% after posting a double beat ...

GOBankingRates was able to find each state’s middle-class income range by sourcing the median household income, total population and households. The middle-class income was then calculated using ...

Eli Lilly is cracking down on unauthorized tirzepatide imitators with lawsuits aimed at four companies allegedly compounding ...